Giuseppe De Luca

16.0k total citations · 2 hit papers
373 papers, 9.9k citations indexed

About

Giuseppe De Luca is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Giuseppe De Luca has authored 373 papers receiving a total of 9.9k indexed citations (citations by other indexed papers that have themselves been cited), including 288 papers in Cardiology and Cardiovascular Medicine, 231 papers in Surgery and 101 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Giuseppe De Luca's work include Acute Myocardial Infarction Research (198 papers), Coronary Interventions and Diagnostics (185 papers) and Antiplatelet Therapy and Cardiovascular Diseases (129 papers). Giuseppe De Luca is often cited by papers focused on Acute Myocardial Infarction Research (198 papers), Coronary Interventions and Diagnostics (185 papers) and Antiplatelet Therapy and Cardiovascular Diseases (129 papers). Giuseppe De Luca collaborates with scholars based in Italy, Netherlands and United States. Giuseppe De Luca's co-authors include Harry Suryapranata, Paolo Marino, Monica Verdoia, Jan Paul Ottervanger, Elliott M. Antman, Alon Schaffer, Arnoud W.J. van ‘t Hof, Ettore Cassetti, Lucia Barbieri and Jan C.A. Hoorntje and has published in prestigious journals such as JAMA, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Giuseppe De Luca

363 papers receiving 9.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Time Delay to Treatment and Mortality in Primary Angioplasty for Acute Myocardial Infarction

2004 1.1k citations Giuseppe De Luca, Harry Suryapranata et al. profile →
Perivascular adipose tissue as a source of therapeutic targets and clinical biomarkers

2023 94 citations Charalambos Antoniades, Dimitris Tousoulis et al. European Heart Journal profile →

Peers

Countries citing papers authored by Giuseppe De Luca

Since Specialization

Citations

This map shows the geographic impact of Giuseppe De Luca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giuseppe De Luca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giuseppe De Luca more than expected).

Fields of papers citing papers by Giuseppe De Luca

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giuseppe De Luca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giuseppe De Luca. The network helps show where Giuseppe De Luca may publish in the future.

Co-authorship network of co-authors of Giuseppe De Luca

This figure shows the co-authorship network connecting the top 25 collaborators of Giuseppe De Luca. A scholar is included among the top collaborators of Giuseppe De Luca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giuseppe De Luca. Giuseppe De Luca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Increased incidence of adverse events in diabetes mellitus patients with combined multiple vulnerable plaque features: new insights from the COMBINE OCT-FFR trial 2024 ·European Heart Journal - Cardiovascular Imaging ·David del Val, Balázs Berta, Tomasz Roleder, Krzysztof Piotr Malinowski, Teresa Bastante, Renicus S. Hermanides, Wojciech Wojakowski, Enrico Fabris, Javier Cuesta, Giuseppe De Luca, Fernando Rivero, F Alfonso, Elvin Kedhi	0
2	Current and Future Roles of Glycoprotein IIb–IIIa Inhibitors in Primary Angioplasty for ST-Segment Elevation Myocardial Infarction 2024 ·Biomedicines ·Giuseppe De Luca, (unknown), Arnoud W.J. van ‘t Hof, Jurriën M. ten Berg, Dean J. Kereiakes, Barry S. Coller, C. Michael Gibson	2
3	ASA Allergy and Desensitization Protocols in the Management of CAD: A Review of Literature 2023 ·Journal of Clinical Medicine ·Monica Verdoia, (unknown), Matteo Nardin, Giuseppe De Luca	2
4	Contemporary Management of Cardiogenic Shock Complicating Acute Myocardial Infarction 2023 ·Journal of Clinical Medicine ·Leonardo De Luca, (unknown), (unknown), Hölger Thiele, Giuseppe De Luca	6
5	Percutaneous Treatment of Left Main Disease: A Review of Current Status 2023 ·Journal of Clinical Medicine ·Dario Pellegrini, Alfonso Ielasi, Maurizio Tespili, Giulio Guagliumi, Giuseppe De Luca	4
6	Platelets and the Atherosclerotic Process: An Overview of New Markers of Platelet Activation and Reactivity, and Their Implications in Primary and Secondary Prevention 2023 ·Journal of Clinical Medicine ·Matteo Nardin, Monica Verdoia, Davide Cao, Simone Nardin, Elvin Kedhi, Gennaro Galasso, Arnoud W.J. van ‘t Hof, Gianluigi Condorelli, Giuseppe De Luca	5
7	Single versus Dual-Operator Approaches for Percutaneous Coronary Interventions within Chronic Total Occlusion—An Analysis of 27,788 Patients 2023 ·Journal of Clinical Medicine ·Rafał Januszek, Giuseppe De Luca, (unknown), Leszek Bryniarski, Krzysztof Piotr Malinowski, Andrzej Surdacki, Wojciech Wańha, Stanisław Bartuś, (unknown), Krzysztof Bartuś, (unknown), Zbigniew Siudak	0
8	Individualization of Duration of Dual Antiplatelet Therapy after Coronary Stenting: A Comprehensive, Evidence-Based Review 2023 ·Journal of Clinical Medicine ·(unknown), Francesco Costa, Victoria Garcia-Ruiz, Mattía Galli, (unknown), (unknown), (unknown), (unknown), Scipione Carerj, Gianluca Di Bella, Antonio Micari, Giuseppe De Luca	1
9	Prognostic significance of the SYNTAX score and SYNTAX score II in patients with myocardial infarction treated with percutaneous coronary intervention 2023 ·Catheterization and Cardiovascular Interventions ·Marco Di Maio, Luca Esposito, Angelo Silverio, Michele Bellino, (unknown), Giuseppe De Luca, (unknown), (unknown), Carmine Vecchione, Gennaro Galasso	1
10	In-stent restenosis after percutaneous coronary intervention: emerging knowledge on biological pathways 2023 ·European Heart Journal Open ·Francesco Pelliccia, Marco Zimarino, Giampaolo Niccoli, Doralisa Morrone, Giuseppe De Luca, Fabio Miraldi, Raffaele De Caterina	23
11	Soluble PCSK9 Inhibition: Indications, Clinical Impact, New Molecular Insights and Practical Approach—Where Do We Stand? 2023 ·Journal of Clinical Medicine ·Michele Bellino, Gennaro Galasso, Angelo Silverio, Michèle Tedeschi, (unknown), (unknown), Luca Esposito, (unknown), (unknown), Giulio Accarino, Monica Verdoia, (unknown), Carmine Vecchione, Giuseppe De Luca	5
12	Antiplatelet Strategies for Older Patients with Acute Coronary Syndromes: Finding Directions in a Low-Evidence Field 2023 ·Journal of Clinical Medicine ·Stefano De Servi, Antonio Landi, Stefano Savonitto, Nuccia Morici, Leonardo De Luca, Claudio Montalto, Gabriele Crimi, Roberta De Rosa, Giuseppe De Luca	9
13	Mechanisms, therapeutic implications, and methodological challenges of gut microbiota and cardiovascular diseases: a position paper by the ESC Working Group on Coronary Pathophysiology and Microcirculation 2022 ·Cardiovascular Research ·Dimitris Tousoulis, Tomasz J. Guzik, Teresa Padró, Dirk J. Duncker, Giuseppe De Luca, Etto C. Eringa, Marija Vavlukis, Alexios S. Antonopoulos, Themistoklis Katsimichas, Edina Cenko, Ana Djordjevic‐Dikic, Ingrid Fleming, Olivia Manfrini, Danijela Trifunović, Charalambos Antoniades, Filippo Crea	32
14	Multivessel vs. culprit-only percutaneous coronary intervention strategy in older adults with acute myocardial infarction 2022 ·European Journal of Internal Medicine ·Claudio Montalto, Nuccia Morici, Aung Myat, Gabriele Crimi, Giuseppe De Luca, Irene Bossi, Adam de Belder, Stefano Savonitto, Stefano De Servi	3
15	Case‐fatality rate of major bleeding events in patients on dual antiplatelet therapy after percutaneous coronary intervention: A systematic review and meta‐analysis 2022 ·Research and Practice in Thrombosis and Haemostasis ·Tobias Tritschler, Anuj Patel, Noémie Kraaijpoel, Deepak L. Bhatt, Giuseppe De Luca, Pietro Di Santo, Fausto Feres, Ricardo A. Costa, Benjamin Hibbert, Takaaki Isshiki, Grégoire Le Gal, Lana A. Castellucci	1
16	Management of acute coronary syndromes in older adults 2021 ·European Heart Journal ·Nuccia Morici, Stefano De Servi, Leonardo De Luca, Gabriele Crimi, Claudio Montalto, Roberta De Rosa, Giuseppe De Luca, Andrea Rubboli, Marco Valgimigli, Stefano Savonitto	38
17	COVID‐19 and Acute Coronary Syndromes: From Pathophysiology to Clinical Perspectives 2021 ·Oxidative Medicine and Cellular Longevity ·Luca Esposito, (unknown), Angelo Silverio, Marco Di Maio, Patrizia Iannece, Antonio Damato, Carmine Alfano, Giuseppe De Luca, Carmine Vecchione, Gennaro Galasso	28
18	Uric acid does not affect the prevalence and extent of coronary artery disease. Results from a prospective study 2010 ·Nutrition Metabolism and Cardiovascular Diseases ·Giuseppe De Luca, Gioel Gabrio Secco, Matteo Santagostino, Luca Venegoni, Sergio Iorio, Ettore Cassetti, Monica Verdoia, Lorenzo Coppo, Carlo Di Mario, Giorgio Bellomo, Paolo Marino	107
19	Patency of infarct related artery after pharmacological reperfusion during transfer to primary percutaneous coronary intervention influences left ventricular function and one-year clinical outcome 2007 ·International Journal of Cardiology ·Dariusz Dudek, Tomasz Rakowski, (unknown), Danuta Sorysz, J Zalewski, Jacek Legutko, Artur Dziewierz, Łukasz Rzeszutko, Krzysztof Żmudka, W Piwowarska, Giuseppe De Luca, Grzegorz L. Kałuża, Marianna Janion, Jacek S. Dubiel	17
20	Adjunctive abciximab to reperfusion therapy in patients with acute st-segment elevation myocardial infarction: A meta-analysis of randomized trials 2005 ·Journal of the American College of Cardiology ·Giuseppe De Luca, Harry Suryapranata, (unknown), D Antoniucci, (unknown), (unknown), Frans Van de Werf, EM Antman, Eric J. Topol	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact